| Product Name | MF | CAS | Details |
|---|
| Menin-MLL inhibitor 26 | C27H29F3N6O3S | 2440018-29-9 | Details |
| BRM/BRG1 ATP Inhibitor-4 | C25H32N6O3S | 2422030-94-0 | Details |
| SARS-CoV-2 3CLpro-IN-7 | C24H17ClN2O6 | 1164478-67-4 | Details |
| Loxoprofenol-SRS tromethamine | C19H31NO6 | 2582872-01-1 | Details |
| BRM/BRG1 ATP Inhibitor-3 | C26H25N5O2S2 | 2368901-31-7 | Details |
| Topoisomerase II inhibitor 7 | C32H28BrN5O5S | 2697171-03-0 | Details |
| CBB1007 hydrochloride | C27H34N8O4.5ClH | 2070014-96-7 | Details |
| Eleven-Nineteen-Leukemia Protein IN-2 | 2894121-78-7 | Details |
| Metallo-β-lactamase-IN-9 | 1802363-75-2 | Details |
| (-)-15-Deoxyspergualin | 89149-10-0 | Details |
| (R,R)-Reboxetine mesylate | C20H27NO6S | 105017-39-8 | Details |
| CB-892 | C15H14N2O4 | 1032336-22-3 | Details |
| Dihydro-β-erythroidine | C16H21N1O3 | 23255-54-1 | Details |
| Velagliflozin proline hydrate | C28H34N2O7 | 1661838-94-3 | Details |
| Cyclic-di-GMP diammonium | C20H27N11O14P2 | 609343-82-0 | Details |
| PF-06815345 hydrochloride | C27H30Cl2FN9O4 | 2334434-49-8 | Details |
| 6-trans-12-epi-Leukotriene B4 | C20H32O4 | 71548-19-1 | Details |
| KRAS G12C inhibitor 37 | C35H39F3N8O2 | 2241720-04-5 | Details |
| KRAS G12C inhibitor 40 | C34H36ClFN10O2 | 2660014-14-0 | Details |
| Antiarrhythmic agent-1 | C25H27N3O4S | 136081-07-7 | Details |
| Antibacterial agent 64 | C29H20ClN3O6S2 | 618865-52-4 | Details |
| MAO-B ligand-1 | C19H19N5O4S | 1010879-39-6 | Details |
| Asterriquinol D dimethyl ether | C26H24N2O4 | 287117-66-2 | Details |
| N 0840 | C11H15N5 | 109292-91-3 | Details |
| P-CAB agent 2 hydrochloride | C22H26ClFN2O4S | 2209911-80-6 | Details |
| KYN-101 | C22H19FN6 | 2247950-73-6 | Details |
| KRAS G12C inhibitor 41 | C36H37ClFN9O2 | 2660014-65-1 | Details |
| 3-Chlorogentisyl alcohol | C7H7ClO3 | 32744-80-2 | Details |
| PI3K/mTOR Inhibitor-13 | C20H13F2N5O3S | 1621718-37-3 | Details |
| Cathepsin K inhibitor 3 | C30H31FN4O4S | 1694638-70-4 | Details |
| Antileishmanial agent-13 | C17H10BrClN4O | 853725-86-7 | Details |
| Antituberculosis agent-6 | C27H20F2N2O3 | 2874263-72-4 | Details |
| KRAS G12D inhibitor 10 | C33H41ClN8O2 | 2648551-54-4 | Details |
| Antibacterial agent 124 | C16H17ClFN3O2 | 2304448-00-6 | Details |
| Hsp90-IN-17 hydrochloride | C21H21ClN4O7 | 1253584-63-2 | Details |
| Phosphoglycolohydroxamic acid | C2H6NO6P | 51528-59-7 | Details |
| Carbonic anhydrase inhibitor 12 | 2883451-38-3 | Details |
| Eleven-Nineteen-Leukemia Protein IN-3 | 2894121-83-4 | Details |
| Tubulin polymerization-IN-40 | 2921670-94-0 | Details |
| Sodium ((2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl diphosphate | C10H16N5NaO11P2 | 9652-27-6 | Details |
| D,L-erythro-PDMP hydrochloride | C23H39ClN2O3 | 80943-40-4 | Details |
| P2X7 receptor antagonist-3 | C17H12ClF3N6O | 1627900-92-8 | Details |
| NK1 receptor antagonist 2 | C31H35F7N4O2 | 579475-17-5 | Details |
| 5-Iminodaunorubicin hydrochloride | C27H31ClN2O9 | 67324-99-6 | Details |
| PI3K/Akt/CREB activator 1 | C19H15F4NO3 | 2708177-73-3 | Details |
| LC kinetic stabilizer-2 | C28H31N3O3 | 2495750-20-2 | Details |
| KRAS G12C inhibitor 35 | C31H27ClF2N6O3 | 2650550-87-9 | Details |
| ADRA1D receptor antagonist 1 free base | C15H13ClN4O | 1191908-24-3 | Details |
| PI3K/mTOR Inhibitor-12 | 2891692-83-2 | Details |
| α-Synuclein inhibitor 8 | 2883627-64-1 | Details |
| 3β-Hydroxy-hop-22(29)-ene | C30H50O | 58801-23-3 | Details |
| Larotinib mesylate hydrate | C25H30ClFN4O7S | 2097129-93-4 | Details |
| DYRKs-IN-1 hydrochloride | C30H31Cl2N7O4 | 1386980-55-7 | Details |
| Antiproliferative agent-20 | C23H18N2O6 | 1344715-94-1 | Details |
| Mitochondria degrader-1 | C33H49ClFN7O8S | 2241669-05-4 | Details |
| Teslexivir hydrochloride | C35H37BrClN3O4 | 1075281-70-7 | Details |
| KRAS G12C inhibitor 45 | C32H33F2N5O5S | 2670380-74-0 | Details |
| Antiproliferative agent-17 | 2882206-08-6 | Details |
| CypD-IN-29 | C26H20FN5O2S | 1115335-95-9 | Details |
| KRAS G12C inhibitor 20 | C33H37ClFN7O3 | 2640858-10-0 | Details |
| Antituberculosis agent-8 | C25H19F3N2O3 | 2874263-74-6 | Details |
| ATM-3507 trihydrochloride | C37H47ClFN5O2 | 2438679-30-0 | Details |
| SRT 1720 dihydrochloride | C25H24ClN7OS | 2468639-77-0 | Details |
| Enpp/Carbonic?anhydrase-IN-2 | C23H24FNO4S | 2883495-39-2 | Details |
| Eleven-Nineteen-Leukemia Protein IN-1 | 2894121-68-5 | Details |
| MRS2768 tetrasodium salt | 2567869-47-8 | Details |
| Mtb-cyt-bd oxidase-IN-6 | 1246461-10-8 | Details |
| SARS-CoV-2 3CLpro-IN-5 | 2913186-57-7 | Details |
| ZINC09410451 | C24H27ClN4O3 | 1093065-66-7 | Details |
| ZINC32540717 | C23H26N4O3 | 1010869-76-7 | Details |
| Difluorocyclooctyne-CH2-COOH | C10H12F2O2 | 1047997-31-8 | Details |
| E09241 | C11H9ClN2O2 | 1043110-13-9 | Details |
| Lagociclovir valactate | C18H25FN6O6 | 1001670-19-4 | Details |
| Antibacterial agent 19 | C16H16F2N2O4 | 79660-59-6 | Details |
| Tilpisertib fosmecarbil | C35H36ClN8O7P | 2567459-64-5 | Details |
| RORγt inverse agonist 26 | C27H21F7N2O5S | 2738333-10-1 | Details |
| β2AR/M-receptor agonist-2 | C36H49ClN4O7S | 1017857-38-3 | Details |
| Crozbaciclib fumarate | C32H34F2N6O4 | 2567494-39-5 | Details |
| KRAS G12C inhibitor 32 | 2756739-00-9 | Details |
| COR167 | C28H38N2O2 | 1048038-90-9 | Details |
| KRAS G12D inhibitor 3 | C34H31ClF3N5O2 | 2757095-11-5 | Details |
| LC kinetic stabilizer-1 | C27H31N5O3 | 2495750-19-9 | Details |
| LDC4297 hydrochloride | C23H29ClN8O | 2319747-14-1 | Details |
| (S)-LY3177833 hydrate | C16H14FN5O2 | 2733342-93-1 | Details |
| Atorvastatin hemicalcium trihydrate | C33H39CaFN2O6 | 344920-08-7 | Details |
| DSP-1053 benzenesulfonate | C32H38BrNO7S | 1176326-78-5 | Details |
| (+)-Dihydrocalanolide A | C22H28O5 | 183904-53-2 | Details |
| (D-Met2,Pro5)-Enkephalinamide | C30H40N6O6S | 63307-63-1 | Details |
| Glucocorticoid receptor modulator 1 | C24H23ClN2O4S | 2868357-11-1 | Details |
| 673-A | C15H13NO | 109437-62-9 | Details |
| Cap-dependent endonuclease-IN-7 | C36H28FN3O7S | 2485715-97-5 | Details |
| KRAS G12C inhibitor 39 | C37H43N9O2 | 2326522-16-9 | Details |
| Neuroinflammatory-IN-3 | C19H19ClO3 | 1202404-23-6 | Details |
| S1P5 receptor agonist-1 | C20H24F3NO3 | 2373330-78-8 | Details |
| Topoisomerase IV inhibitor 2 | C33H30FN7O6S | 2883403-36-7 | Details |
| Topoisomerase IV inhibitor 1 | 2883403-42-5 | Details |
| Anti-inflammatory agent 33 | C22H15N3O5S | 2816993-09-4 | Details |
| Ladostigil hydrochloride | C16H21ClN2O2 | 209394-18-3 | Details |
| SARS-CoV-2 3CLpro-IN-6 | C22H15NO7 | 302821-53-0 | Details |
| ST101036 | C18H21F3N4 | 1018143-39-9 | Details |
| Product Total： Product Page： | ||||
| 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 | ||||